What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Created BSURE Medical, a new spin-off of the VHIR The creation of BSURE Medical represents the culmination of the valuation and transfer strategy carried out by the VHIR Innovation Unit of a research project of which Dr. Jaume Alijotas Reig and Dr. Simo Schwartz Jr are the main researchers and promoters. News Vall d'Hebron will study the placental tissue of women infected by the SARS-CoV-2 virus during pregnancy The study is carried out together with the Italfarmaco group and is analyzing the placentas of approximately 100 women who have suffered COVID-19 during their pregnancy. News Bufa la bombolla reaches its goal and raises 10.000 euros for research in primary immunodeficiencies The benefits of the solidarity campaign of Vall d'Hebron and the Barcelona PID Foundation are dedicated to research in primary immunodeficiencies at the Vall d'Hebron Research Institute (VHIR). The initiative had the support of Abacus, which has been the point of sale for the solidarity jars of Bufa News Five professionals from Vall d’Hebron, among the top 100 in the State according to Forbes magazine Forbes magazine has published the list "The best doctors", which recognizes the 100 most relevant medical professionals, divided into 24 specialties. News VHIR opens the Seniority Call in the modalities of ERC and No ERC The Vall d'Hebron University Hospital Foundation - Research Institute (VHIR) makes its own, open and unique call, for the recruitment of excellent researchers. News Inauguration of the exhibition of scientific photographs of Vall d’Hebron at Palau Robert The exhibition 'L'altra mirada de la recerca' (The Other Look at Research) can be visited at Palau Robert from 13th January to 28th February. News Patented a peptide that allows faster internalization of drugs within cells and the design of more effective therapeutic nanoconjugates The CIBBIM-Nanomedicine: Drug Delivery and Targeting research group at the Vall d'Hebron Institute of Research (VHIR), led by Dr. Simó Schwartz Jr, has developed this promising technology, now patented. News A study in which the VHIR has participated discovers a new pediatric disease The VHIR has recently participated in an international study, coordinated by the Children's Hospital of Philadelphia, which has led to the discovery of a new pediatric neurodegenerative disease. News New position paper on the design of clinical trials in patients with decompensated cirrhosis This guide has been carried out within the LiverHope Consortium, founded by the European Commission under the Horizon 2020 program. News Demonstrated the usefulness of cardiac MRI in a subgroup of patients with myocardial infarction Magnetic resonance imaging offers greater diagnostic power over echocardiography and can predict adverse events. News Posa’t la Gorra Balaguer makes a new donation to VHIR for pediatric cancer research The Posa't la Gorra Balaguer initiative continues to support childhood cancer research through the organization of some activities aimed at promoting awareness of the disease. News Vall d’Hebron exhibits a collection of 10 years of scientific photographs at Palau Robert In these 10 years, more than 600 photographs have been submitted to the competition, of which 120 have been winners and are now part of the exhibition 'The other look of research'. News Pre-registration for the 8th edition of the Master in Translational Biomedical Research of the VHIR The pre-registration period for the academic year 2021-2022 of the Master in Translational Biomedical Research of the VHIR will be open from January 11 to September 6 2021, or until the available places are exhausted. News One in four patients admitted to the ICU with COVID-19 suffers a thrombosis, which in many cases is asymptomatic The study, carried out with 230 patients at the ICUs of the Vall d'Hebron and Germans Trias i Pujol University Hospitals, is the world's largest published series of patients with COVID-19 and thrombosis in the ICU. News Vall d’Hebron includes the world’s first patient in Pfizer’s Phase 3 gene therapy clinical trial for Duchenne muscular dystrophy Vall d'Hebron became the first center in the world to include a patient (a 5-year-old boy) in the phase 3 gene therapy clinical trial for Duchenne muscular dystrophy. News Vall d’Hebron designs boxes with humanizing illustrations to cover the serums of pediatric patients The Superbox initiative aims to provide an innovative tool for pediatric patients so that they can live the medication experience more positively and increase their well-being. News Presentació del Nou Pla Estratègic Recerca Vall d’Hebron 2021-2025 El passat 2 de Desembre de 2020 es va aprovar el nou Pla Estratègic del VHIR 2021-2025 per part del Patronat del VHIR, on es defineixen les línies generals d'actuació de la recerca de Vall d'Hebron per tal d'afrontar els nous reptes i necessitats de futur dels propers anys. News The AECC Scientific Foundation provides a grant to Dr. Marco Inzitari for the study of cancer in the elderly. Dr. Marco Inzitari has been awarded a competitive grant for the study of cancer in the elderly, awarded by the Scientific Foundation of the Spanish Association Against Cancer (AECC). News Vall d'Hebron begins clinical trial of Janssen's Covid-19 vaccine This week Vall d'Hebron has started recruiting volunteers to participate in the phase III clinical trial of the Covid-19 vaccine from Janssen Pharmaceuticals (Johnson & Johnson). News Vall d'Hebron suggests that the immune system through a cytotoxic attack of T lymphocytes would cause Parkinson's disease This study may become a first step in definitively determining the cause of Parkinson's disease and in establishing new therapeutic targets to stop or even prevent the disease. Pagination First page « Previous page ‹ … Page 59 Page 60 Current page 61 Page 62 Page 63 … Next page › Last page »
